Clarity Pharmaceuticals Ltd
Clinical trials sponsored by Clarity Pharmaceuticals Ltd, explained in plain language.
-
New 'See and Treat' approach targets Hard-to-Treat prostate cancer
Disease control Recruiting nowThis study tests two copper-based drugs that work together: one helps doctors see prostate cancer tumors on scans, and the other delivers targeted radiation to kill them. The trial involves 54 men with a type of advanced prostate cancer that no longer responds to hormone therapy.…
Phase: PHASE1, PHASE2 • Sponsor: Clarity Pharmaceuticals Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Sharper eye for prostate cancer: new imaging agent aims to spot hidden spread
Diagnosis Recruiting nowThis phase 3 trial tests a new radioactive imaging agent, 64Cu-SAR-bisPSMA, to see if it can better detect prostate cancer that has spread to nearby lymph nodes. About 383 men with high-risk prostate cancer will receive a single injection of the agent before their scheduled prost…
Phase: PHASE3 • Sponsor: Clarity Pharmaceuticals Ltd • Aim: Diagnosis
Last updated Jun 27, 2026 12:33 UTC